GenSight Biologics S.A. (FRA:G49N)
Germany · Delayed Price · Currency is EUR 0.0960
+0.0026 (2.78%)
At close: Nov 28, 2025
GenSight Biologics Market Cap
GenSight Biologics has a market cap or net worth of €19.15 million as of December 1, 2025. Its market cap has decreased by -46.79% in one year.
Market Cap
19.15M
Enterprise Value
37.89M
Revenue
945.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.10
Market Cap Chart
Since July 13, 2016, GenSight Biologics's market cap has decreased from 252.15M to 19.15M, a decrease of -92.41%. That is a compound annual growth rate of -24.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 19.32M | -41.54% |
| Dec 31, 2024 | 33.05M | 28.79% |
| Dec 29, 2023 | 25.66M | -83.46% |
| Dec 30, 2022 | 155.20M | -39.23% |
| Dec 31, 2021 | 255.38M | -16.09% |
| Dec 31, 2020 | 304.35M | 275.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.88B |
| Siemens Aktiengesellschaft | 176.79B |
| Allianz SE | 141.56B |
| Deutsche Telekom AG | 132.19B |
| Siemens Energy AG | 98.23B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.85B |
| Rheinmetall AG | 67.93B |
| Deutsche Bank Aktiengesellschaft | 58.37B |